The Effects of CD40L on the Phenotypes and IL-12 Secretion of B Lymphocytes
Shen Su-Nan,Xu Zhi,Qian Xiao-Ping,Yu Li-Xia,Liu Bao-Rui
DOI: https://doi.org/10.3321/j.issn:0469-5097.2007.05.003
2007-01-01
Abstract:Dendritic cells(DCs) constitute only 0.1%~0.5% of human peripheral blood mononuclear cells(PBMCs),and in 2~3 weeks,DCs cease to proliferate and become less efficient in presenting antigen.Therefore,we chose CD40L to activate B lymphocytes in vitro and determined the expression of the surface molecular and IL-12 secretion of B lymphocytes to evaluate the advantage of B lymphocytes as Antigen Presenting Cells(APC) in antitumor immunity.Peripheral blood mononuclear cells(PBMCs) obtained from 7 healthy adult donors were isolated by Ficoll centrifugation.The experimental group PBMCs were cultured by RMPI 1640 supplemented with 10% fetal calf serum(FCS),sCD40L(2μg/mL) and recombinant human interleukin-4(IL-4)(4ng/mL) for 21 days.The proliferation of B lymphocytes was observed.In the day 7,14 and 21,the expressions of CD80,CD86 and CD19 were determined respectively by flow cytometry analysis system(FCAS).The level of interleukin-12(IL-12) produced upon the cultured B lymphocytes was measured by using enzyme-linked immunosorbent assay(ELISA) on the day 21.The results show that the activated B lymphocytes were easily expandable and could from large clones and there was a high expression of CD80/CD86 and CD19.The expression of CD80 is 0.05%(7d),11.94%(14d) and 27.56%(21d),respectively.The expression of CD86 is 1.17%(7d),9.51%(14d) and 21.32%(21d),respectively.The expression of CD19 is 3.03%(7d),15.23%(14d) and 58.66%(21d),respcetively.Comparing the results with that of the control group,we found that the level of IL-12 generated by B lymphocytes was up-regulated(P<0.05).These results show that B lymphocytes may be used as alternative APC for the induction of antigen-specific CD8+T cell(CTL) responses,which might be used in tumor immunotherapy.